Brief introduction: Shenzhen Ruike Biotechnology Co., Ltd. is a biotechnology company engaged in liquid biopsy, functional nucleic acid fragment detection, immunotherapy and microbial engineering. Founded in the great development period of Shenzhen life science industry, the company closely follows the general direction of precision medicine, systematically integrates the detection, treatment and prevention of major diseases into the life science industry, and transforms outstanding scientific research achievements into technical services and products needed by the market. First of all, in the field of molecular biology, the company focuses on the prevention of major diseases and the development and application of molecular diagnosis technology to help improve the diagnosis and treatment effect of diseases such as tumors and provide personalized human health management. Secondly, in the field of immunotherapy research and application, Ricco Biotechnology Co., Ltd. cooperated with Wuhan University of Science and Technology to carry out the research of chimeric antigen receptor T cell immunotherapy (CAR-T) technology, and provided basic support for its clinical experiments in the south in terms of cell expansion. In microbial and macromolecular engineering transformation, Ricco mainly involves the extraction, research and development of natural products and the utilization of bioengineering. On the one hand, we will transform the bioengineering achievements involved in the company, and on the other hand, we will continue to upgrade and improve the bioengineering scientific research projects involved by using the achievements of basic biology research and molecular biology technology.
Legal Representative: Guo Wei.
Established: 20 15-03-3 1
Registered capital: 5 million yuan.
Industrial and commercial registration number: 440301112468253.
Enterprise type: limited liability company
Company address: 4th floor, Building A 12, Benkang Industrial Park, Kwai Chung Street, Dapeng New District, Shenzhen.